The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Share News (MTFB)

  • There is currently no data for MTFB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: M&A Speculation And Upgrade Boost Morrisons

Thu, 03rd Sep 2015 09:42

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.
----------
FTSE 100 - WINNERS
----------
easyJet, up 6.3%. The low-cost airline upgraded its full-year profit guidance following a strong summer trading season. The FTSE 100 airline said its pretax profit for the financial year to the end of September is now expected to be GBP675 million to GBP700 million, up from its previous guidance of GBP620 million to GBP660 million. The group said its strong revenue performance over the summer has more than offset any cost challenges it has faced this year and said it passenger numbers and load factor both hit record levels in August.

Wm Morrison Supermarkets, up 4.8%. The supermarket was in demand after a report in The Daily Telegraph suggested South African billionaire Christo Wiese is now training his sights on the UK supermarket industry. Wiese, who owns a 19% stake in frozen food retailer Iceland and who has been linked with a takeover of Wm Morrison Supermarkets PLC in the past, told the Telegraph that his investment firm, Brait, may make its next venture in the UK supermarket sector. The stock was also upgraded Thursday to Neutral from Sell by UBS, with a price target of 175p, up from 165p. It was quoted at 169.90p Thursday morning.
----------
FTSE 250 - WINNERS
----------
Lookers, up 6.7%. The motor retailer and aftersales services provider said it has struck an GBP87.5 million cash deal to acquire Addison Motors, which trades as Benfield Motor Group. Benfield is based in Newcastle-upon-Tyne and operates 30 car dealerships across the UK, offering sales, service, parts and bodyshop facilities for new and used cars and commercial vehicles, Lookers said. Analysts hailed the deal, with Numis describing the acquisition as a "major step" for Lookers. The broker said that "the new company helps to consolidate Lookers' position with key original equipment manufacturers and dovetails nicely in terms of location," adding it expects the acquisition to raise Lookers' level of profitability "significantly".

Virgin Money Holdings, up 3.0%. Investec upgraded the financial services provider to Buy from Hold, saying the economic fundamentals which will drive its share price performance are all positive at present.
----------
FTSE 250 - LOSERS
----------
Go-Ahead Group, down 6.7%. The transport operator said its annual pretax profit was pulled lower by exceptional costs, but said its underlying performance was strong and its revenue surged higher thanks to stronger-than-expected trading in its rail unit. Still, it expects to hit its GBP100 million operating profit target for the bus operations in the 2016-17 financial year, a year later than it had anticipated. Its pretax profit for the year to June 27 was GBP78.7 million, down from GBP91.2 million a year earlier, as the group booked GBP8.8 million in exceptional costs, having booked a GBP12.1 million gain a year earlier. Stripping out exceptional costs, Go-Ahead's pretax profit was up to GBP96.6 million from GBP84.9 million.
----------
MAIN MARKET AND AIM - WINNERS
----------
African Potash, up 13%. The company said it has signed its third and largest offtake agreement to supply fertiliser through its previously signed agreement to build a production and distribution platform for fertiliser in Africa. The company has signed a memorandum of understanding with an unnamed Zimbabwean fertiliser supply company to provide 150,000 metric tonnes of fertiliser per year.

Dart Group, up 10%. The leisure travel, distribution and logistics company said it is confident its full-year results will materially outpace market expectations following robust summer trading in its leisure travel arm and a solid performance in its Fowler Welch unit. Dart said the early indications for the winter season in the leisure travel arm are satisfactory, but it said it has seen continued strong demand over the summer months for its package holiday and flight-only products. Dart also said it has entered into a deal with aerospace giant Boeing to buy 27 new Boeing 737-800NG aircraft, to be delivered between September 2016 and April 2018.

Motif Bio, up 8.6%. The biopharmaceutical company said the US Food and Drug Administration has granted fast-track designation to its Iclaprim drug. The intravenous drug is used to treat acute bacterial skin and skin structure infections and hospital-acquired bacterial pneumonia. Amphion Innovations, up 8.8%, also benefited from the rise in value of Motif Bio shares in the first half and its shares were higher on the back of the Motif Bio news.
----------
MAIN MARKET AND AIM - LOSERS
----------
Forbidden Technologies, down 12%. The company which owns and develops cloud video platform Forscene and video social network eva, said it made a GBP1.4 million pretax loss in the six months to June 30, compared with GBP1.2 million in the corresponding half the prior year. Revenue was down to GBP327,338 from GBP348,077, while operating costs rose to GBP1.4 million from GBP1.3 million. Deferred and future revenue from agreed deals increased to GBP220,000 from GBP33,000 six months earlier.
----------
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
17 Jul 2015 06:40

Motif Bio's Iclaprim Eligible For Incentives With New US Designation

Read more
23 Jun 2015 11:20

Motif Bio raises £22m via share placing

Biopharmaceutical company Motif Bio has raised £22m via a conditional share placing with institutional investors. The London-listed group said "the placing is conditional on securing shareholder approval and on a successful qualified infection disease product designation being given to its iclaprim

Read more
23 Jun 2015 09:28

Amphion Innovations Confident After Motif IPO, 2014 Asset Value Fall

Read more
23 Jun 2015 06:58

Motif Bio Raises GBP22 Million In Discounted Share Placing (ALLISS)

Read more
9 Jun 2015 08:27

Motif Bio Annual Loss Widened Slightly Ahead Of London IPO

Read more
1 Jun 2015 11:15

Motif Bio signs deal with leading clinical research organisation

A wholly-owned subsidiary of antibiotic developer Motif Bio has signed letters of intent and interim agreements with a leading global clinical research organisation (CRO). Motif has agreed to invest more than $0.95m under the agreements, which must be paid by the end of July. Under the agreements,

Read more
1 Jun 2015 07:23

Motif Bio Shares Up As It Moves Towards Iclaprim Clinical Trials

Read more
28 May 2015 09:47

Motif Bio Gets FDA Minutes Confirming Phase III Plans For Iclaprim

Read more
7 May 2015 09:12

Motif Bio Exploring Funding Options For Iclaprim Trials (ALLISS)

Read more
15 Apr 2015 07:31

LONDON MORNING BRIEFING: Next And Burberry Shares In Fashion

Read more
15 Apr 2015 07:10

Amphion Shares Up As Motif Bio Gets US FDA Approval For Iclaprim Trial

Read more
2 Apr 2015 11:46

Motif Bio makes AIM debut, seeks approval for Iclaprim treatment

Clinical stage biopharmaceutical group Motif Bio began trading on AIM on Thursday, after raising £2.8m in its initial public offering. The group, whose 44.09% of issued equity is owned by Amphion, placed shares at 20p each, said it had 64,238,442 ordinary shares in issue and a market capitalisation

Read more
2 Apr 2015 08:19

BCA Marketplace, Marshall Motor And Motif Bio Begin Trading (ALLIPO)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.